Webinar: Investigating Inflammatory Disease using Humanized Cytokine Mice
Our webinar “Investigating Inflammatory Disease using Humanized Cytokine Mice” was live on Dec 1, 2021 at 1PM.
In this webinar, we will:
– Review the range of cytokines associated with various autoimmune and allergy related diseases
– Describe some of the inflammatory disease models we have developed including asthma, atopic dermatitis, and psoriasis
– Introduce various humanized cytokine mouse models that can be used in disease modeling
– Detail some of the typical readouts for these models and discuss validation data our teams have produced in these models
About the Speaker & Panelists
Clarke Gasper, Ph.D.
Senior Business Development Manager, Biocytogen Boston
Dr. Clarke Gasper’s research experience ranges from protein biochemistry and structural biology to antibody production and small molecule drug development. He began his research at San Diego State University working on the myosin chaperone protein UNC-45. He then went on to Caltech, where he was part of the NIH ENCODE research consortium managing their transcription factor antibody production pipeline and developed a fully automated chromatin immunoprecipitation assay for identifying transcription factor binding sites in the human genome. He went on to receive his Ph.D. in biochemistry from Boston University where he helped identify several small-molecules, lead candidates for treating diabetes and obesity. After 13 years in scientific research, he has joined Biocytogen, where he is currently a senior business development manager.
Jenna Frame, Ph.D. Manager, Scientific Communications & Marketing, Biocytogen Boston
Dr. Jenna Frame has worked with mouse and zebrafish models in the hematology field for over 15 years at the University of Rochester and Harvard Medical School. At Biocytogen, Jenna helps provide researchers with the information they need to select quality animal models and other preclinical services to advance their research pipeline.
Q & A:
Qingcong Lin, Ph.D. Senior Vice President and CEO of Biocytogen Boston
Dr. Lin has extensive research expertise in the field of molecular genetics. He has held leadership positions at Wyeth and Pfizer, and has served as the Director of the Laboratory for Genetic Engineering at the Center for Genetics and Genomics Research at Harvard Medical School. In 2018, Dr. Lin joined Biocytogen as the Senior Vice President and President of Biocytogen Boston. He is fully responsible for the company’s US and EU business development, including licensing the use of RenMab mice, the external authorization and cooperative development of therapeutic antibody candidates, including pharmacology and efficacy studies, and development of gene targeting business.
Save your free spot now: https://biocytogen.zoom.us/webinar/register/WN_TI92vTkOTmmavHnnjQaYYQ